Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
12/2003
12/31/2003WO2003072036A3 Treatment methods using anti-cd22 antibodies
12/31/2003WO2003066662A3 Protein purification
12/31/2003WO2003064471A3 Gene for peripheral arterial occlusive disease
12/31/2003WO2003055912A3 Secreted proteins
12/31/2003WO2003048208A3 Expression control using variable intergenic sequences
12/31/2003WO2003039486A3 Anti-cd80 antibody having adcc activity for adcc mediated killing of b cell lymphoma cells alone or in combination with other therapies
12/31/2003WO2003037911A3 Antibodies for inhibiting blood coagulation and methods of use thereof
12/31/2003WO2003022879B1 Peptides mimicking a cryptic epitope of gp41 hiv-1 and antibodies directed against them
12/31/2003WO2003020759A9 A caspase- 8 binding protein, its preparation and use
12/31/2003WO2002077648A3 Pathogenic and commensal vaccine antigens
12/31/2003WO2002070562A3 Nuclear hormone receptor ligand binding domain
12/31/2003WO2002055668A3 Nucleotide sequences encoding variable regions of heavy and light chains of monoclonal antibody 1f7
12/31/2003WO2002042444A3 Fungal gene cluster associated with pathogenesis
12/31/2003WO2002040671A3 Immunoglobulin superfamily proteins
12/31/2003WO2002038766A3 Human tumor necrosis factor receptor
12/31/2003WO2002031198A3 Cancer-linked genes as targets for chemotherapy
12/31/2003WO2001064710A8 Sulfated ccr5 peptides for hiv-1 infection
12/31/2003CN1464908A Multivalent antibodies and uses therefor
12/31/2003CN1464309A Usage of alpha-mannosidase in the immunocyte subgroup sectionalization and method thereof
12/31/2003CN1464068A Human brain tissue specificity molecular marker LRRC4
12/31/2003CN1464057A Chemokine-like factor superfamily having skeletal muscle stimulating activity and immunoregulation function
12/31/2003CN1464053A New polypeptide-Glycosyl 12 and polynucleotides for coding same
12/31/2003CN1464052A New polypeptide-human RNA uncoiling enzyme 95 and polynucleotides for coding same
12/31/2003CN1464049A New polypeptide-human sailer transposase 11 and polynucleotides for coding same
12/31/2003CN1463985A Process for selectively separating IgY antibody from anseriforme birds eggs and IgY antibody produced therefrom
12/31/2003CN1463749A Anti-sphagitis specificity composite IgY and preparation thereof
12/31/2003CN1132939C Coding sequence of pyrophosphate synthetase, its encoded polypeptide and its preparing process
12/31/2003CA2490747A1 Method for generating monoclonal antibodies
12/31/2003CA2490746A1 Nucleotide sequences that code for torsin genes, torsin proteins, and methods of using the same to treat protein-aggregation
12/31/2003CA2490423A1 Buffered formulations for concentrating antibodies and methods of use thereof
12/31/2003CA2490399A1 Novel raag10 cell surface target and a family of antibodies recognizing that target
12/31/2003CA2490009A1 Serum protein-associated target-specific ligands and identification method therefor
12/31/2003CA2489540A1 Methods of treating and preventing colitis involving il-13 and nk-t cells
12/31/2003CA2489057A1 Compositions and methods for apo-b48 and apo-b100 assay
12/31/2003CA2486490A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
12/30/2003US6670466 Human endogenous retrovirus in breast cancer
12/30/2003US6670464 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
12/30/2003US6670453 Crosslinking, agglutination, purification
12/30/2003US6670450 Polypeptide that inhibits the differentiation of myoblasts into myotubes as well as the transactivation function of p53, a transcription factor involved in tumor suppression.
12/30/2003US6670321 Prevention and treatment for retinal ischemia and edema
12/30/2003US6670183 88kDa tumorigenic growth factor and antagonists
12/30/2003US6670181 Compositions and methods for treating viral infections
12/30/2003US6670165 Generation preferential hydrolase; obtain sample containing hydrolase, incubate with phosphotransferase, recover hydrolase
12/30/2003US6670164 Isolated human kinase proteins
12/30/2003US6670160 Enzymatic polypeptide; for the diagnosis and detection of mammalian tumors
12/30/2003US6670140 Determining whether test compound binds to receptor, selecting compound that binds, determining whether compound increases muscle mass or function in skeletal muscle atrophy model system, identifying compound that modulates mass or function
12/30/2003US6670136 Peptide for use in the treatment of inflammation defects
12/30/2003US6670135 Assaying the binding of a DCSema polypeptide to a VESPR protein.
12/30/2003US6670134 Identifying modulators of the receptor, especially by measuring the increase or decrease in adenylate cyclase activity.
12/30/2003US6670123 Method for detecting hematopoietic stem cells
12/30/2003US6669946 Therapy; diagnosis; T cells recognize and interact with complexes of cell surface molecules such as human leukocyte antigens or major histocompatibility complexes
12/30/2003US6669941 Administering drugs comprising tumor necrosis factor adrenergic blocking agents conjugated to immunoglobulins for the prophylaxis of rheumatoid arthritis, multiple sclerosis or diabetes
12/30/2003US6669938 ImmunoConjucates for cancer diagnosis and therapy
12/30/2003US6669937 Monoclonal antibody antagonists for treating medical problems associated with d-amphetamine-like drugs
12/30/2003CA2380690C Human osteoclast-derived cathepsin
12/30/2003CA2215727C Hybrid phthalocyanine derivatives and their uses
12/30/2003CA2163641C Multiple sclerosis virus
12/25/2003WO2003106497A1 Monoclonal antibody pam4 and its use for diagnosis and therapy of pancreatic cancer
12/25/2003WO2003106495A2 MONOCLONAL ANTIBODY hPAM4
12/25/2003US20030237101 Stem cell factor; modulation of gene expression
12/25/2003US20030236392 Genetic engineering; polypeptide library
12/25/2003US20030236389 Proteins, polynucleotides encoding them and methods of using the same
12/25/2003US20030236210 Detection and modulation of Slit and roundabount (Robo) mediated angiogenesis and uses thereof
12/25/2003US20030236209 Compositions and methods for the therapy and diagnosis of lung cancer
12/25/2003US20030236193 Methods of treatment using specific binding agents of human angiopoietin-2
12/25/2003US20030236182 Therapeutic and diagnostic methods for ulcerative colitis and associated disorders
12/25/2003US20030235908 Adjusting lymphocyte concentration; closed container; discharging filter
12/25/2003US20030235901 Detoxification using amylase; drug screening analysis
12/25/2003US20030235900 Anticancer agents
12/25/2003US20030235898 Nematode GS-like sequences
12/25/2003US20030235897 Immunological control of beta-amyloid levels in vivo
12/25/2003US20030235891 Method for generating monoclonal antibodies
12/25/2003US20030235880 Genetic engineered nucleic acid
12/25/2003US20030235869 Biological products
12/25/2003US20030235868 Antibodies specific for mucin polypeptide
12/25/2003US20030235861 Multimolecular, two-dimensional lattice or aggregate comprising immobilized cd antigens and monoclonal antibodies for monitor protein binding activity; competetive binding bioassay; treating cancer, allergies and inflammation
12/25/2003US20030235853 Solid phase synthesis; for drug screening
12/25/2003US20030235842 Map
12/25/2003US20030235838 Common polymorphism in scn5a implicated in drug-induced cardiac arrhythmia
12/25/2003US20030235823 Nucleotide sequences that code for torsin genes, torsin proteins, and methods of using the same to treat protein-aggregation
12/25/2003US20030235820 Detecting and identifying tumor related transcripts associated with cancer; screening and monitoring antiproliferative agents
12/25/2003US20030235818 Identifying amino acid sequences which mimic epitopes of target proteins such as shigella toxin, hepatitis viral coat protein and anthrax lethal factor for development of genetic vacines
12/25/2003US20030235815 Synthetic peptides that bind to the hepatitis B virus core and E antigens
12/25/2003US20030235592 Moraxella catarrhalis protein, gene sequence and uses thereof
12/25/2003US20030235587 Anticoagulant agents useful in treatment of thrombosis
12/25/2003US20030235586 Can be produced in a transfectoma or in a non-human transgenic animal capable of producing multiple isotypes of human monoclonal antibodies by undergoing V-D-J recombination and isotype switching
12/25/2003US20030235585 Methods of treating disorders in which TFN alpha activity is detrimental via biweekly, subcutaneous administration of human antibodies, preferably recombinant human antibodies, that specifically bind to human tumor necrosis factor alpha
12/25/2003US20030235584 Method for preparing anti-MIF antibodies
12/25/2003US20030235582 Anti-IGF-I receptor antibody
12/25/2003US20030235578 Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of Gram positive bacteria
12/25/2003US20030235556 Combination IL-2/anti-HER2 antibody therapy for cancers characterized by overexpression of the HER2 receptor protein
12/25/2003US20030235555 Antiasthmatics
12/25/2003US20030235533 A nucleic acid sequence that is expressed by human prostate cancer cells, an expressed antigen that elicits antibodies, diagnostic kit comprising a monoclonal antibody is used to detect prostate cancer
12/24/2003WO2003107249A1 Method for predicting a drug transport capability by abcg2 polymorphisms
12/24/2003WO2003107003A1 Positive identification of phospho-proteins using motif-specific, context-independent antibodies coupled with database searching
12/24/2003WO2003106974A2 Diagnosis and treatment of chemoresistant tumors
12/24/2003WO2003106697A2 Method and kit for identifying pseudomonas aeruginosa
12/24/2003WO2003106695A2 Methods and compositions for in vivo clearance of pathogens
12/24/2003WO2003106692A2 Methods for the identification of all-antigens and their use for cancer therapy and transplantation
12/24/2003WO2003106684A2 A method for simultaneous production of multiple proteins; vectors and cells for use therein